CD123-NKCE

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameCD123-NKCE
Drug Alias NameCD123-NKCE
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin-3 receptor subunit alpha inhibitorsLow affinity immunoglobulin gamma Fc region receptor III-A agonists
TargetsInterleukin-3 receptor subunit alphaLow affinity immunoglobulin gamma Fc region receptor III-A
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSanofiInnate Pharma
China Registration ClassN/A

Develop Information

Active CompaniesSanofiInnate Pharma
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A